Navigation Links
Research reveals control of potent immune regulator

A new study reveals how the production of a potent immune regulator called interferon gamma (IFNg) is controlled in natural killer (NK) cells, immune cells that typically defend the body against cancer and infections.

IFNg, produced by NK cells and other cell types, plays a critical role in killing pathogen-infected cells and in defending against tumor cells. However, overproduction of IFNg is also dangerous to the body and can cause autoimmune diseases. But exactly how the body tightly controls IFNg production ?and, therefore, NK-cell activity ?is not known.

The study, published in the May issue of the journal Immunity, looked at substances called pro-inflammatory cytokines, which cause NK cells to make IFNg and stimulate their activity. It also looked at transforming growth factor beta (TGFb), a substance also made by NK cells that lowers IFNg production.

The research, by investigators with the Ohio State University Comprehensive Cancer Center ?Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, found that the pro-inflammatory cytokines not only cause NK cells to make IFNg, but they also shut down TGFb signaling, which inhibits production of IFNg.

That is, the cytokines not only increase some positive regulators of IFNg production, but they also shut down the TGFb signals that inhibit IFNg production.

In addition, the scientists found that TGFb turns down IFNg production ?and, therefore, NK cell activity ?both directly and indirectly.

The direct mechanism turns off the IFNg gene itself. The indirectly mechanism blocks a protein that normally turns up IFNg production.

"Our findings provide important details about the fine balance between positive and negative regulators of IFNg production in NK cells," says principal investigator Michael A. Caligiuri, director of the OSU Comprehensive Cancer Center. "Mother Nature uses a symphony of cytokines that result in exquisitely tight control of its production in the healthy state.

"This might help us harness the cancer-killing ability of NK cells to control tumor growth and lead to new treatments that complement current cancer therapy," he says.

The body carefully regulates IFNg levels. If there is too little of the substance, the risk of infection and cancer rises. If there is too much IFNg, NK cells become too plentiful and autoimmune diseases such as inflammatory bowel disease can occur.

"Our findings explain the yin and yang of the system that controls NK cells," says first author Jianhua Yu, a post-doctoral student in Caligiuri's laboratory. "When NK cells are called into action, the body not only turns up the activation pathway, it also shuts down the anti-activation pathway."

Likewise, when TGFb turns down NK cell activity, it not only turns off the IFNg gene, it also shuts down the pathway that activates the gene.

"In each instance, these regulatory cytokines deliver a double whammy," Caligiuri says. "They turn on what is needed and turn off anything that interferes with it."


'"/>

Source:Ohio State University


Related biology news :

1. Researchers discover way to make cells in the eye sensitive to light
2. Quantum Dots Research Leads to New Knowledge about Protein Binding in Plants
3. Researchers find how protein allows insects to detect and respond to pheromones
4. Researchers Uncover Key Step In Manufacture of Memory Protein
5. Research advances quest for HIV-1 vaccine
6. Research on Worms Yields Clues on Aging
7. Researchers reveal the infectious impact of salmon farms on wild salmon
8. Researchers identify target for cancer drugs
9. Weill Cornell Research Reveals Secrets Of Trafficking Within Cells
10. Researchers discover molecule that causes secondary stroke
11. Researchers find missing genes of ancient organism
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/13/2017)... , April 13, 2017 UBM,s Advanced ... will feature emerging and evolving technology through ... Innovation Summits will run alongside the expo portion of ... sessions, panels and demonstrations focused on trending topics within ... advanced design and manufacturing event will take place June ...
(Date:4/11/2017)... 11, 2017 NXT-ID, Inc. (NASDAQ:   ... announces the appointment of independent Directors Mr. Robin D. ... Board of Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , ... forward to their guidance and benefiting from their considerable expertise ...
(Date:4/4/2017)... YORK , April 4, 2017   EyeLock ... today announced that the United States Patent and Trademark ... patent broadly covers the linking of an iris image ... same transaction) and represents the company,s 45 th ... latest patent is very timely given the multi-modal biometric ...
Breaking Biology News(10 mins):
(Date:9/22/2017)... ... September 22, 2017 , ... Brain State ... via Kickstarter. The proceeds will be used to fund production of the company’s ... original Kickstarter goal by nearly 1,000%. , The B2v2 is the world’s first ...
(Date:9/22/2017)... (PRWEB) , ... September 22, 2017 , ... ... colleague Dr. Justin Zalewsky in offering LANAP® and LAPIP™ laser treatments. Drs. Hoge ... True Regeneration™ to patients, a minimally invasive and less painful option that produces ...
(Date:9/22/2017)... ... September 22, 2017 , ... ... ulcers is now being assessed in clinical trials in the United States. (clinicaltrials.gov ... to your nurse or physician or find your nearest participating clinic here ...
(Date:9/21/2017)... ... September 21, 2017 , ... Dr. Greg Leyer, Chief Scientific Officer of ... 27th. His presentation is at 12:10pm in the Probiotics Resource Center, Mandalay Bay Expo ... West and discuss how probiotics have shown impressive data in areas outside the gut ...
Breaking Biology Technology: